“…In the present study, biochemical liver tests (LFT) typically showed a "hepatitic" (with or without cholestatic) pattern of abnormalities, as serum aminotransferase activity and bilirubin concentrations varied widely from very mildly abnormal to more than 50 fold rise the upper normal limits in all patients with AILDs and cryptogenic chronic hepatitis, but the hyperbilirubinemia is notably cholestatic in all patients (100%) with overlap syndromes, as it was associated with alkaline phosphatase elevation more than 3 time the upper normal limit. This observation is in coincidence with many other studies [14,15,16], they classified overlap syndrome as an "intermediate level between cholestatic form of AIH or hepatic form of cholestatic syndromes". The hypergammaglobulinemia, which is the most reliable laboratory parameter in AILDs, was increased in this study in all patients with AILDs and much higher value were observed in type I AIH with average 2.5 g/dl, when compared to other types of AILDs, this observation also recorded by Porta and Squires [16,17].…”